Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ELETRIPTAN HYDROBROMIDE

ELETRIPTAN HYDROBROMIDE

Standard Dose
40MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview ELETRIPTAN HYDROBROMIDE is listed in Drugs@FDA under application 201536 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ELETRIPTAN HYDROBROMIDE Form and strength TABLET; ORAL - 40MG Sponsor APOTEX INC Submission history Latest submission status date: 2013-07-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ELETRIPTAN HYDROBROMIDE is listed in Drugs@FDA under application 201536 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ELETRIPTAN HYDROBROMIDE Form and strength TABLET; ORAL - 40MG Sponsor APOTEX INC Submission history Latest submission status date: 2013-07-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.
ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE) | Drug Monograph | MedicHelpline